Michael J. Dittbenner

Michael J. Dittbenner currently serves as the Executive Director of the Thought Leader Liaison Team for Rare Disease at ANI Pharmaceuticals, Inc., a position held since April 2023. Prior to this role, Dittbenner was with Alexion Pharmaceuticals, Inc. since February 2018, where responsibilities included Director of Thought Leader Strategy for U.S. Neurology. Dittbenner's extensive experience in the pharmaceutical industry includes roles such as Associate Director of Neurology at Mallinckrodt Pharmaceuticals and various positions at Questcor Pharmaceuticals, Biogen Idec, Cephalon, and The Janssen Pharmaceutical Companies of Johnson & Johnson. Dittbenner holds a Bachelor of Science degree in Kinesiology and Exercise Science from Northern Michigan University and an MBA in Marketing from Saint Joseph's University.